Corcept Therapeutics Incorporated (CORT) — Cash Flow-to-Debt Ratio
Corcept Therapeutics Incorporated (CORT) has a Cash Flow-to-Debt Ratio of -0.09x as of March 2026, meaning its operating cash flow of $-16.77 Million could theoretically repay 0% of its total liabilities ($176.89 Million) in one year. See CORT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Corcept Therapeutics Incorporated Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Corcept Therapeutics Incorporated across 23 annual periods. Also explore Corcept Therapeutics Incorporated (CORT) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Corcept Therapeutics Incorporated (2003–2025)
Year-by-year debt coverage analysis for Corcept Therapeutics Incorporated. For market capitalisation and broader financial context, see market value of Corcept Therapeutics Incorporated.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | $142.00 Million | $188.85 Million | ▼ -38.9% |
| 2024 | 1.23x | $198.07 Million | $160.96 Million | ▲ +11.2% |
| 2023 | 1.11x | $127.04 Million | $114.81 Million | ▼ -25.0% |
| 2022 | 1.47x | $120.32 Million | $81.59 Million | ▼ -57.9% |
| 2021 | 3.50x | $167.89 Million | $47.95 Million | ▲ +11.5% |
| 2020 | 3.14x | $151.97 Million | $48.39 Million | ▼ -5.1% |
| 2019 | 3.31x | $136.12 Million | $41.13 Million | ▲ +2.5% |
| 2018 | 3.23x | $115.67 Million | $35.81 Million | ▲ +56.7% |
| 2017 | 2.06x | $60.94 Million | $29.57 Million | ▲ +206.7% |
| 2016 | 0.67x | $18.39 Million | $27.37 Million | ▲ +617.8% |
| 2015 | 0.09x | $3.13 Million | $33.44 Million | ▲ +113.0% |
| 2014 | -0.72x | $-27.38 Million | $38.02 Million | ▲ +18.3% |
| 2013 | -0.88x | $-37.06 Million | $42.06 Million | ▲ +8.5% |
| 2012 | -0.96x | $-36.02 Million | $37.39 Million | ▲ +82.3% |
| 2011 | -5.45x | $-27.40 Million | $5.03 Million | ▲ +5.6% |
| 2010 | -5.77x | $-22.29 Million | $3.86 Million | ▲ +22.3% |
| 2009 | -7.43x | $-17.97 Million | $2.42 Million | ▼ -16.0% |
| 2008 | -6.40x | $-18.36 Million | $2.87 Million | ▼ -75.8% |
| 2007 | -3.64x | $-10.96 Million | $3.01 Million | ▲ +44.5% |
| 2006 | -6.56x | $-23.24 Million | $3.54 Million | ▼ -35.6% |
| 2005 | -4.84x | $-17.23 Million | $3.56 Million | ▲ +35.7% |
| 2004 | -7.52x | $-13.72 Million | $1.82 Million | ▼ -15.6% |
| 2003 | -6.51x | $-10.00 Million | $1.54 Million | — |